ʼһ

XClose

Sustainable Development Goals

Home
Menu

Discovery of a molecular switch that controls immune responses could lead to new treatment

A critical control point within the body’s immune system could hold the key to new treatments for autoimmune disease such as diabetes and multiple sclerosis.

SDG Case study G3.4-Jenner

8 October 2020

Acritical componentof the body’simmune systems control mechanismshas been identifiedfor the first timebyscientistsworking at ʼһandtheUniversity of Manchester.

“Manyintricate processesare taking place constantlywithin ourcellsandtissuesthattogetherprotect us from infection, remove rogue cells that could become cancerousandcontrol over-zealousimmuneresponses,”explains Professor Richard Jenner (UCL CancerInstitute), who led the projectat ʼһ.

If the immune system's regulatory mechanismsthat create an immune responsefail,it can start to attack its own cells and tissues–a process called autoimmunity.

Professor Jennercollaborated withtheUniversity of Manchesteraspart of a ten-year study looking at the regulatory networks within the immune system.

Our findings represent a significant step forward inourunderstanding ofhowimmuneresponses are regulatedand wehopemany people worldwidewillbenefit"

Recently,theteamuncovered amolecular pathway thatincludesa tiny molecular‘masterswitch’–known as microRNA-142. The moleculeis part of the inner workings of the cell and canswitchparticular geneson and offtoregulatewhichproteins are made. This in turndetermineswhich cellsare ‘activated’ to create an immune response.

Autoimmune diseasessuch asdiabetes and multiple sclerosis affect people world-wide andoften target people in the prime of their life,creating a significant socio-economic burden.

“Ourfindings represent a significant step forward inourunderstanding ofhowimmuneresponses are regulatedand wehopemany people worldwidewill,”saysProfessorJenner.

MicroRNA-142 controlsimmune cells calledRegulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, researchers found, the most highly expressed regulator of this type in the immune system.

By modulating this pathway is may be possibletoharness the therapeutic power of the immune system to treat diseases including cancer, diabetes, multiple sclerosis and Crohn’s diseasein the future.